Literature DB >> 11718721

Respiratory chain network in mitochondria of Candida parapsilosis: ADP/O appraisal of the multiple electron pathways.

G Milani1, W Jarmuszkiewicz, C M Sluse-Goffart, A Z Schreiber, A E Vercesi, F E Sluse.   

Abstract

In this study we demonstrated that mitochondria of Candida parapsilosis contain a constitutive ubiquinol alternative oxidase (AOX) in addition to a classical respiratory chain (CRC) and a parallel respiratory chain (PAR) both terminating by two different cytochrome c oxidases. The C. parapsilosis AOX is characterized by a fungi-type regulation by GMP (as a stimulator) and linoleic acid (as an inhibitor). Inhibitor screening of the respiratory network by the ADP/O ratio and state 3 respiration determinations showed that (i) oxygen can be reduced by the three terminal oxidases through four paths implying one bypass between CRC and PAR and (ii) the sum of CRC, AOX and PAR capacities is higher than the overall respiration (no additivity) and that their engagement could be progressive according to the redox state of ubiquinone, i.e. first cytochrome pathway, then AOX and finally PAR.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11718721     DOI: 10.1016/s0014-5793(01)03060-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Inhibition of Candida parapsilosis mitochondrial respiratory pathways enhances susceptibility to caspofungin.

Authors:  Georgios Chamilos; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 2.  Mitochondria and fungal pathogenesis: drug tolerance, virulence, and potential for antifungal therapy.

Authors:  Miguel Shingu-Vazquez; Ana Traven
Journal:  Eukaryot Cell       Date:  2011-09-16

3.  Inhibition of specific electron transport pathways leads to oxidative stress and decreased Candida albicans proliferation.

Authors:  Fernando Ruy; Anibal E Vercesi; Alicia J Kowaltowski
Journal:  J Bioenerg Biomembr       Date:  2006-10-12       Impact factor: 2.945

Review 4.  Candida parapsilosis: from Genes to the Bedside.

Authors:  Renáta Tóth; Jozef Nosek; Héctor M Mora-Montes; Toni Gabaldon; Joseph M Bliss; Joshua D Nosanchuk; Siobhán A Turner; Geraldine Butler; Csaba Vágvölgyi; Attila Gácser
Journal:  Clin Microbiol Rev       Date:  2019-02-27       Impact factor: 26.132

Review 5.  Biology and genetics of the pathogenic yeast Candida parapsilosis.

Authors:  Jozef Nosek; Zuzana Holesova; Peter Kosa; Attila Gacser; Lubomir Tomaska
Journal:  Curr Genet       Date:  2009-08-07       Impact factor: 3.886

6.  The alternative respiratory pathway of euglena mitochondria.

Authors:  Norma A Castro-Guerrero; Klaas Krab; Rafael Moreno-Sánchez
Journal:  J Bioenerg Biomembr       Date:  2004-10       Impact factor: 2.945

7.  Enzymatic dysfunction of mitochondrial complex I of the Candida albicans goa1 mutant is associated with increased reactive oxidants and cell death.

Authors:  Dongmei Li; Hui Chen; Abigail Florentino; Deepu Alex; Patricia Sikorski; William A Fonzi; Richard Calderone
Journal:  Eukaryot Cell       Date:  2011-03-11

Review 8.  Targeting the alternative oxidase (AOX) for human health and food security, a pharmaceutical and agrochemical target or a rescue mechanism?

Authors:  Marten Szibor; Christina Schenkl; Mario R O Barsottini; Luke Young; Anthony L Moore
Journal:  Biochem J       Date:  2022-06-30       Impact factor: 3.766

9.  Capsule Enlargement in Cryptococcus neoformans Is Dependent on Mitochondrial Activity.

Authors:  Nuria Trevijano-Contador; Suelen A Rossi; Elisabete Alves; Santiago Landín-Ferreiroa; Oscar Zaragoza
Journal:  Front Microbiol       Date:  2017-07-31       Impact factor: 5.640

10.  Mitochondrial function in the yeast form of the pathogenic fungus Paracoccidioides brasiliensis.

Authors:  Vicente P Martins; Frederico M Soriani; Taisa Magnani; Valéria G Tudella; Gustavo H Goldman; Carlos Curti; Sérgio A Uyemura
Journal:  J Bioenerg Biomembr       Date:  2008-09-17       Impact factor: 3.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.